New Mexico Oncology Hematology
Albuquerque, New Mexico 87109
We've found
1 trials
at this facility
Clinical Trial
Updated: 12/31/1969
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
